• 8 years ago
LOS ANGELES — Maria Sharapova announced on Monday that she failed a drug test at the Australian Open in January.

At a press conference in Los Angeles, she said she received a letter on March 2 from the International Tennis Federation but has not yet found out what her punishment will be.

ESPN reports that the ITF confirmed the failed test and said Sharapova would be provisionally suspended until the case is finalized.

"I take great responsibility and professionalism in my career every day," Sharapova said at a press conference on Monday, according to ESPN. "I made a huge mistake. I let my fans down. I let my sport down."

"I know that with this, I face consequences," the tennis star said. "I don't want to end my career this way, and I really hope I will be given another chance to play this game."

The five-time Grand Slam winner said she has been taking the drug mildronate, also known as meldonium, for 10 years to address a number of health issues.

Meldonium is a Latvian drug used in Russia and Eastern Europe to treat heart conditions. Meldonium is a blood-flow promoting drug banned because it can boost oxygen uptake and endurance.

The drug wasn't declared a banned substance by the World Anti-Doping Agency until the start of 2016. Sharapova said that when the agency sent an email about the changes in December, she did not click on the link to see that the substance had been added to the list.

Nike has already suspended its relationship with Sharapova. Will other sponsors follow Nike's lead?

----------------------------------------­­---------------------

Welcome to TomoNews, where we animate the most entertaining news on the internets. Come here for an animated look at viral headlines, US news, celebrity gossip, salacious scandals, dumb criminals and much more! Subscribe now for daily news animations that will knock your socks off.

Visit our official website for all the latest, uncensored videos: http://us.tomonews.net
Check out our Android app: http://bit.ly/1rddhCj
Check out our iOS app: http://bit.ly/1gO3z1f

Get top stories delivered to your inbox everyday: http://bit.ly/tomo-newsletter

Stay connected with us here:
Facebook http://www.facebook.com/TomoNewsUS
Twitter @tomonewsus http://www.twitter.com/TomoNewsUS
Google+ http://plus.google.com/+TomoNewsUS/
Instagram @tomonewsus http://instagram.com/tomonewsus

Category

🗞
News

Recommended